NASDAQ:RAIN Rain Oncology (RAIN) Stock Price, News & Analysis → The Next Nvidia? (From InvestorPlace) (Ad) Free RAIN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.21▼$1.2150-Day Range$1.20▼$1.2452-Week Range$0.82▼$11.32VolumeN/AAverage Volume550,818 shsMarket Capitalization$44.02 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Rain Oncology alerts: Email Address Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. About Rain Oncology Stock (NASDAQ:RAIN)As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.Read More Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. RAIN Stock News HeadlinesApril 22, 2024 | mirror.co.ukBritain's Got Talent winners now - soap fame, cancer recovery and a tragic deathApril 19, 2024 | msn.comSouth Carolina doctors recommend screenings for head and neck cancerApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 18, 2024 | omaha.comPrince William returns to public duties for first time since Kate's cancer diagnosisApril 18, 2024 | mirror.co.ukWhere the original five Oasis members are now - heart attack, divorces and tonsil cancerApril 18, 2024 | msn.comPrince William makes first public appearance since Kate’s cancer diagnosisApril 16, 2024 | uk.sports.yahoo.comRain washes away tonight’s Chicago White Sox game vs. the Kansas City RoyalsApril 14, 2024 | msn.comFounder of 'The Cure Starts Now' takes message on cancer research to WashingtonApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 12, 2024 | msn.comDeadly weather pummels much of Gulf Coast with tornadoes, torrential rainApril 12, 2024 | sports.yahoo.comRain forces postponement of Twins-Tigers game. They’ll play a doubleheader on SaturdayApril 12, 2024 | msn.comColumbus Weather: Rain sticks around Thursday; severe storms possible this afternoonApril 12, 2024 | msn.comHeavy rain and gusty winds will make for a messy Friday in MaineApril 12, 2024 | msn.comGusty wind, occasional rain, thunder leads to a raw and unpleasant Saturday nextApril 11, 2024 | msn.comOJ Simpson dead of cancer at 76April 11, 2024 | msn.comO.J. Simpson dies at 76 after battle with cancer, family saysApril 11, 2024 | msn.comWeather Impact Day on Thursday due to heavy rain, stormsApril 10, 2024 | msn.comGreen family cycling team beat rain, snow and hills to reach John O'GroatsApril 10, 2024 | msn.comExperimental treatment would help patients grow new liversApril 10, 2024 | msn.comWeather Impact Day on Thursday due to heavy rainApril 9, 2024 | mirror.co.ukWoman with mastectomy scars will be first to run London Marathon topless after cancer fightApril 9, 2024 | msn.comBrave cancer survivors' 80-mile charity walk from Stoke-on-Trent to WalesApril 8, 2024 | msn.comRathdrum Cancer Support officially opens new facilityApril 3, 2024 | msn.comNor'easter Will Bring Heavy Rain, Gusty Winds, SnowApril 2, 2024 | msn.comShannen Doherty has decided to 'downsize' as she lives with stage 4 cancerApril 2, 2024 | msn.comArizona congressman Raúl Grijalva says he has cancer, but plans to work while undergoing treatmentApril 2, 2024 | chicago.suntimes.comRyne Sandberg, fighting prostate cancer, throws out first pitch at Cubs’ home openerSee More Headlines Receive RAIN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rain Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:RAIN CUSIPN/A CIK1724979 Webwww.rainthera.com Phone510-953-5559FaxN/AEmployees63Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-75,720,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-82.96% Return on Assets-68.31% Debt Debt-to-Equity RatioN/A Current Ratio5.58 Quick Ratio5.58 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.11 per share Price / Book0.39Miscellaneous Outstanding Shares36,380,000Free Float30,047,000Market Cap$44.02 million OptionableOptionable Beta0.27 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Avanish Vellanki M.B.A. (Age 49)Co-Founder, CEO & Chairman Comp: $959.75kDr. Robert C. Doebele M.D. (Age 53)Ph.D., Co-Founder, Chairman of Scientific Advisory Board, President & CSO and Chief Medical Officer Comp: $700.56kMs. Josephine Bruce (Age 45)Principal Financial & Accounting officer Ms. Theresa O'Connell M.S.Director of Corporate Development & OperationsMr. Erik Atkisson (Age 52)General Counsel & Chief Compliance Officer Ms. Charmi TurnerVice President of People & CultureMs. Vijaya Tirunagaru Ph.D.Senior VP & Head of ResearchDr. Nora Ku M.D.MD & VP of Clinical DevelopmentMore ExecutivesKey CompetitorsSAB BiotherapeuticsNASDAQ:SABSBioLineRxNASDAQ:BLRXBrainstorm Cell TherapeuticsNASDAQ:BCLILianBioNASDAQ:LIANAcasti PharmaNASDAQ:ACSTView All CompetitorsInsiders & InstitutionsPenderFund Capital Management Ltd.Bought 38,650 shares on 2/14/2024Ownership: 0.106%Russell Investments Group Ltd.Sold 370,925 shares on 2/5/2024Ownership: 0.069%Marquette Asset Management LLCBought 17,388 shares on 2/2/2024Ownership: 0.279%BML Capital Management LLCBought 1,276,081 shares on 1/30/2024Ownership: 3.708%Kevin C TangSold 40,132 sharesTotal: $48,559.72 ($1.21/share)View All Insider TransactionsView All Institutional Transactions RAIN Stock Analysis - Frequently Asked Questions Should I buy or sell Rain Oncology stock right now? 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rain Oncology in the last twelve months. There are currently 10 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RAIN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RAIN, but not buy additional shares or sell existing shares. View RAIN analyst ratings or view top-rated stocks. How were Rain Oncology's earnings last quarter? Rain Oncology Inc. (NASDAQ:RAIN) issued its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by $0.06. When did Rain Oncology IPO? Rain Oncology (RAIN) raised $126 million in an initial public offering (IPO) on Friday, April 23rd 2021. The company issued 7,400,000 shares at $16.00-$18.00 per share. Goldman Sachs, Citigroup, Piper Sandler and Guggenheim Securities served as the underwriters for the IPO. This page (NASDAQ:RAIN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rain Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
